Table 4.

Pearson correlation results for TSQM, GIS, and SF-12

		TSQM vII				GIS
		Effectiveness	Side effects	Convenience	Global satisfaction	Gout overall concern	Gout medication side effects	Unmet gout treatment needs	Gout concern during attack	Well-being during attack
TSQM vII	Effectiveness	1.00
	Side effects	0.16	1.00
	Convenience	0.49	0.30	1.00
	Global satisfaction	0.67	0.35	0.76	1.00
GIS	Gout overall concern	−0.34	−0.22	−0.29	−0.38	1.00
	Gout medication side effects	−0.25	−0.46	−0.35	−0.44	0.59	1.00
	Unmet gout treatment need	−0.40	−0.20	−0.39	−0.50	0.52	0.34	1.00
	Gout concern during attack	−0.06	−0.25	−0.17	−0.15	0.54	0.53	0.28	1.00
	Well-being during attack	0.09	−0.23	0.02	0.02	0.26	0.34	0.11	0.61	1.00
SF-12	Physical functioning	0.15	0.13	0.10	0.11	−0.23	−0.09	−0.12	−0.15	−0.09
	Role physical	0.13	0.26	0.11	0.16	−0.25	−0.17	−0.20	−0.18	−0.19
	Bodily pain	0.12	0.12	0.06	0.10	−0.24	−0.14	−0.17	−0.16	−0.17
	General health	0.00	0.22	0.01	0.03	−0.13	−0.07	−0.03	−0.16	−0.11
	Vitality	0.11	0.15	0.13	0.17	−0.30	−0.23	−0.26	−0.22	−0.20
	Social functioning	0.16	0.22	0.14	0.19	−0.26	−0.22	−0.22	−0.28	−0.20
	Role emotional	0.09	0.35	0.12	0.20	−0.22	−0.33	−0.05	−0.27	−0.26
	Mental health	0.12	0.16	0.15	0.22	−0.29	−0.30	−0.20	−0.32	−0.25
	PCS	0.12	0.16	0.06	0.08	−0.21	−0.06	−0.16	−0.12	−0.10
	MCS	0.10	0.27	0.16	0.24	−0.28	−0.38	−0.18	−0.34	−0.29

Notes: Color key: (image) >0.60; (image) 0.50–0.59; (image) 0.40–0.49; 0.30–0.39.

Abbreviations: TSQM vII, Treatment Satisfaction Questionnaire for Medication version II; GIS, Gout Impact Scale; SF-12, SF-12v2^® Health Survey; PCS, physical component summary; MCS, mental component summary.